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CDC Recom m endations for State and Local Planning for a 2009 Novel H1N1 
Influenza Program
The purpose of this document is to describe planning scenarios for state and local governments to target high- 
priority populations for vaccination in order to reduce the health and societal impact of the novel H1N1 influenza 
virus.
Background
Data from U.S. and international sources suggests that it is appropriate to plan for a vaccination program to 
reduce the health and societal impacts of the novel H1N1 influenza virus. In order to increase the probability of 
success of such a program, planning scenarios should be provided to state and local health authorities promptly. 
Planning scenarios can facilitate readiness to implement specific plans within states and large cities, improving 
the chances that vaccine will reach target populations when recommendations are made, and that distribution, 
delivery, and communication efforts regarding vaccination will overcome local challenges and maximize 
capacities.
Ongoing analysis through the summer of available data on the epidemiology and virologic characteristics of 2009- 
H1N1 virus and about vaccine efficacy will guide decisions about features of the program. These decisions will be 
made in collaboration with expert panels and with input from the public. For example, CDC's Advisory Committee 
on Immunization Practices will provide specific vaccination recommendations, including specific target 
populations and priorities for circumstances of limited or phased vaccine supply. In addition, the National Vaccine 
Advisory Committee will provide guidance on implementation and evaluation of vaccine safety. A public 
engagement effort will also seek input from citizens from several regions around the country about these matters. 
While additional data are collected and reviewed, state and local public health authorities need to accelerate their 
outreach to health care providers, the private sector, occupational groups, and others to put in place mechanisms 
and to develop vaccination venues appropriate to reach groups most likely to be included in a vaccination 
program against pandemic H1N1 influenza.
Rationale Used in Developing the Planning Scenarios
The particular configuration of the vaccination program in each state and local jurisdiction will be determined by 
the population groups for which vaccine is recommended, and vaccination planning needs to encompass the 
diverse venues where vaccine might be delivered. Identification of highly affected populations to date can 
highlight venues that need to be ready to administer vaccine to the various populations that might be included in 
the program, and provide the rationale for the planning scenarios. Populations included in planning scenarios are 
based on the best current data to facilitate state and local planning.
Evidence to date suggests that population immunity to this virus is low, particularly among the young. In one small 
serologic study of samples collected during 2006-08, cross-reacting antibody were found among some older 
persons but not in any younger adults or children. Widespread susceptibility to this virus among young persons 
creates the potential for large numbers of cases with more hospitalizations and deaths among younger age 
groups than would be expected for a typical routine seasonal influenza virus. Importantly, severe disease and
death caused by novel H1N1 thus far have affected younger adults, children, and pregnant women, in addition to
persons of all ages with certain underlying medical conditions more than the elderly. The virus has also caused 
numerous outbreaks in schools and summer camps.
Planning Assumptions
These planning scenarios are based on the following assumptions at the time vaccine becomes available and 
distribution begins:
a) severity of illness is unchanged from what has already been observed
b) risk groups affected by this virus do not change significantly
c) vaccine testing suggests safe and efficacious product
d) adequate supplies of vaccine can be produced
e) no major antigenic changes are evident that would signal the lack of likely efficacy of the vaccines being
produced
Planning Scenarios
The following are best-case planning scenarios that would be recommended in a setting of limited initial vaccine 
availability.
Target population: Students and staff (all ages) associated with schools (K-12th grade) and children (age 
>6 months) and staff (all ages) in child care centers.
Primary venues: schools and child care centers.
Goals: Provide direct protection against illness among persons who have high attack rates of illness, reduce 
likelihood of outbreaks that may lead to disruptive school dismissals, reduce transmission from schools into 
homes and the community.
Adherence to these guidelines will require state and local authorities to carry out extensive planning to reach 
school-aged populations either through venues such as school-associated mass vaccination efforts, or, where 
private capacity is sufficient, through local pediatric providers. Local pediatric care providers may play a 
particularly prominent role in vaccinating preschool-aged children who have a medical home. These planning 
efforts will reinforce longer-term immunization targets of strengthening vaccination efforts in these populations, 
and building links between health and education. The disruptive outbreaks prevalent in schools and some
universities in the spring of 2009 may provide impetus for these planning steps to move forward actively. They will 
also permit strengthening capacity for seasonal influenza vaccination of school-aged children in future seasons.
Target population: Pregnant women, children 6 months - 4 years of age, new parents and household 
contacts of children <6 months of age.
Primary venues: Provider offices, community clinics.
Goal: Reduce complications of novel H1N1 influenza, such as excess hospitalizations and deaths among those 
vulnerable for serious complications of influenza, as evidenced by higher rates of hospitalization; protect the 
youngest (<6 months) who are not themselves able to be vaccinated through immunization of their household 
contacts.
Sustaining a focus on pregnant women and young children is appropriate given their high rates of complications 
and hospitalizations to date, and is consistent with tier 1 prioritization for these groups in pre-pandemic planning.
Target population: Non-elderly adults (age <65 years) with medical conditions that increase the risk of 
complications of influenza.
Primary venues: Occupational settings, community clinics, pharmacies, providers' offices. (Experience with 
seasonal influenza vaccine suggests that persons with underlying illness age 50 to 64 years may be more likely to 
receive vaccine from their provider, while younger persons may be more likely to be vaccinated elsewhere).
Goal: Reduce risk of hospitalizations and deaths among persons with higher rates of these complications than the 
general population, and focus vaccine where its impact can be most beneficial for direct protection.
The planning requirement to offer vaccine to young adults with risk factors will permit state and local authorities to 
address a group that does not frequently seek health care and has relatively low rates of vaccination against 
seasonal influenza. Links with occupational clinics, adult providers, or contingency plans for community venues or 
pharmacies are all options that might address this important at-risk group.
Target population: Health care workers and emergency services sector personnel (regardless of age).
Primary venue: Occupational settings, providers' offices.
Goal: Reduce risk of illness, sustain health system functioning, and reduce absenteeism among front-line 
providers; reduce transmission from emergency services personnel and health care workers to patients; provide 
additional worker protection in settings of increased exposure; reinforce importance of influenza vaccination 
among all health care workers.
Note: Immunization of military (e.g., deployed forces) may be appropriate given the current circumstances; 
however, this memo focuses on vaccination of civilian populations under the authority of CDC and state and local 
health departments.
Vaccine Availability Considerations
If vaccine is widely available, CDC would recommend offering vaccine at multiple venues to anyone who wants to 
be vaccinated. Although the benefits of vaccine may be greatest in the persons in groups at increased risk, and 
interest in being vaccinated may be lower among the general population, offering vaccine to everyone can reduce 
the risk of influenza for general population may reduce transmission to unvaccinated persons. At the same time, if 
vaccine supply is limited, it will be important to consider a balance between international needs for vaccine in 
relation to the vaccination of low risk individuals in the United States.
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by 
preventing and controlling diseases and injuries; enhances health decisions by providing credible 
information on critical health issues; and promotes healthy living through strong partnerships with
local, national and international organizations.
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